Cite

HARVARD Citation

    Sugimoto, M. et al. (2017). Letter: CYP3A4/5 genotype status and outcome of vonoprazan‐containing Helicobacter pylori eradication therapy in Japan. Alimentary pharmacology & therapeutics. 45 (7), pp. 1009-1010. [Online]. 
  
Back to record